"Diabetic macular edema (DME)"- Market Insights, Epidemiology and Market Forecast-2020

  • ID: 3645147
  • Drug Pipelines
  • Region: Global
  • 70 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
This Diabetic macular edema (DME) - Market Insights, Epidemiology and Market Forecast-2020” report provides an overview of the disease and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic macular edema (DME) forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic macular edema (DME) till 2020.

Key Coverage and Benefits

- The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic macular edema (DME) market.
- Identifying patient populations in the global “Diabetic macular edema (DME)market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Diabetic macular edema (DME) therapeutics in each of the markets covered.
- To understand the future market competition in the global Diabetic macular edema (DME) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
- It also provides Diabetic macular edema (DME) for United States, EU5 and Japan from 2010 and forecasted Market to 2020.

Note*: This report requires 5-10 business days to complete.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Table of Contents

- Diabetic macular edema (DME) overview
- Pathophysiology
- Symptoms of disease
- Etiology of disease
- Diagnosis of disease
- Treatment of disease
- Overview of Marketed drugs
- Drug Description
- Mechanism of Action
- Pharmacokinetics Properties
- Marketed Details
- Patent Information
- Patent Exclusivity Expiry Assessment United States (US)
- Patents Details
- Historical and Forecasted sales of marketed molecules in the Global Diabetic macular edema (DME) Market
- Global Epidemiology of Diabetic macular edema (DME) Forecasted to 2020
- Global Market (2011-2015)
- Global Forecasted Market (2016-2020)
- Global Market by Geography
- Market of US (2011-2015)
- Forecasted Market of US (2016-2020)
- Market of Europe
- Market of Germany (2011-2015)
- Forecasted Market of Germany (2016-2020)
- Market of United Kingdom (2011-2015)
- Forecasted Market of United Kingdom (2016-2020)
- Market of France (2011-2015)
- Forecasted Market of France (2016-2020)
- Market of Italy (2011-2015)
- Forecasted Market of Italy (2016-2020)
- Market of Spain (2011-2015)
- Forecasted Market of Spain (2016-2020)
- Market of Japan (2011-2015)
- Forecasted Market of Japan (2016-2020)
- Market of ROW (2011-2015)
- Forecasted Market of ROW (2016-2020)
- Appendix
- Report Methodology
- Consulting Services
- Disclaimer
- Report Purchase Options
- About us

List of Tables

- Table 1: Drug Description
- Table 2: Drug, Marketed Details United States (US)
- Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
- Table 4: Drug, Patent Details for US
- Table 5: Diabetic macular edema (DME) Drug Sales (USD Millions)-2020
- Table 6: Global Epidemiology of Diabetic macular edema (DME) (2011-2020)
- Table 7: Diabetic macular edema (DME) Global Market (USD Millions), (2011-2015)
- Table 8: Diabetic macular edema (DME) Global Market (USD Millions), (2016-2020)
- Table 9: Diabetic macular edema (DME) US Market (USD Millions), (2011-2015)
- Table 10: Diabetic macular edema (DME) US Market (USD Millions), (2016-2020)
- Table 11: Diabetic macular edema (DME) Germany Market (USD Millions), (2011-2015)
- Table 12: Diabetic macular edema (DME) Germany Market (USD Millions), (2016-2020)
- Table 13: Diabetic macular edema (DME) United Kingdom Market (USD Millions), (2011-2015)
- Table 14: Diabetic macular edema (DME) United Kingdom Market (USD Millions), (2016-2020)
- Table 15: Diabetic macular edema (DME) France Market (USD Millions), (2011-2015)
- Table 16: Diabetic macular edema (DME) France Market (USD Millions), (2016-2020)
- Table 17: Diabetic macular edema (DME) Italy Market (USD Millions), (2011-2015)
- Table 18: Diabetic macular edema (DME) Italy Market (USD Millions), (2016-2020)
- Table 19: Diabetic macular edema (DME) Spain Market (USD Millions), (2011-2015)
- Table 20: Diabetic macular edema (DME) Spain Market (USD Millions), (2016-2020)
- Table 21: Diabetic macular edema (DME) Japan Market (USD Millions), (2011-2015)
- Table 22: Diabetic macular edema (DME) Japan Market (USD Millions), (2016-2020)
- Table 23: Diabetic macular edema (DME) ROW Market (USD Millions), (2011-2015)
- Table 24: Diabetic macular edema (DME) ROW Market (USD Millions), (2016-2020)

List of Figures

- Figure 1: Diabetic macular edema (DME) Drug Sales (USD Millions)-2020
- Figure 2: Global Epidemiology of Diabetic macular edema (DME) (2011-2020)
- Figure 3: Diabetic macular edema (DME) Global Market (USD Millions), (2011-2015)
- Figure 4: Diabetic macular edema (DME) Global Market (USD Millions), (2016-2020)
- Figure 5: Diabetic macular edema (DME) US Market (USD Millions), (2011-2015)
- Figure 6: Diabetic macular edema (DME) US Market (USD Millions), (2016-2020)
- Figure 7: Diabetic macular edema (DME) Germany Market (USD Millions), (2011-2015)
- Figure 8: Diabetic macular edema (DME) Germany Market (USD Millions), (2016-2020)
- Figure 9: Diabetic macular edema (DME) United Kingdom Market (USD Millions), (2011-2015)
- Figure 10: Diabetic macular edema (DME) United Kingdom Market (USD Millions), (2016-2020)
- Figure 11: Diabetic macular edema (DME) France Market (USD Millions), (2011-2015)
- Figure 12: Diabetic macular edema (DME) France Market (USD Millions), (2016-2020)
- Figure 13: Diabetic macular edema (DME) Italy Market (USD Millions), (2011-2015)
- Figure 14: Diabetic macular edema (DME) Italy Market (USD Millions), (2016-2020)
- Figure 15: Diabetic macular edema (DME) Spain Market (USD Millions), (2011-2015)
- Figure 16: Diabetic macular edema (DME) Spain Market (USD Millions), (2016-2020)
- Figure 17: Diabetic macular edema (DME) Japan Market (USD Millions), (2011-2015)
- Figure 18: Diabetic macular edema (DME) Japan Market (USD Millions), (2015-2020)
- Figure 19: Diabetic macular edema (DME) ROW Market (USD Millions), (2011-2015)
- Figure 20: Diabetic macular edema (DME) ROW Market (USD Millions), (2016-2020)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll